Form 8-K - Current report:
SEC Accession No. 0001683168-23-001360
Filing Date
2023-03-07
Accepted
2023-03-07 16:06:21
Documents
13
Period of Report
2023-03-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT aclarion_8k-030323.htm   iXBRL 8-K 35130
  Complete submission text file 0001683168-23-001360.txt   255694

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE acon-20230303.xsd EX-101.SCH 3993
3 XBRL DEFINITION FILE acon-20230303_def.xml EX-101.DEF 26648
4 XBRL LABEL FILE acon-20230303_lab.xml EX-101.LAB 36765
5 XBRL PRESENTATION FILE acon-20230303_pre.xml EX-101.PRE 25272
7 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_8k-030323_htm.xml XML 5554
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 23712627
SIC: 8071 Services-Medical Laboratories